We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 913

FDA Finalizes Policy for Sharing Patient-Specific Data from Medical Devices
  • Reed Smith LLP
  • USA
  • November 15 2017

FDA recently released guidance ("Manufacturers Sharing Patient-Specific Information from Medical Devices with Patients Upon Request") finalizing its


Health Hacking: Dealing with the cyber threat in digital health
  • Corrs Chambers Westgarth
  • Australia
  • September 1 2017

Software and the electronic devices it controls, has become increasingly important in the healthcare industry over recent years. Digital health


FDA Makes Moves to Advance Digital Health
  • Epstein Becker Green
  • USA
  • August 17 2017

At the end of July, FDA released a tangible plan for promoting innovation in the development of digital health products. In this Digital Health


Washington Healthcare Update - Aug 14, 2017
  • McGuireWoods LLP
  • USA
  • August 14 2017

Thirty-one Democratic Senators have written CMS Administrator Seema Verma urging her to drop a proposed rule that would require prospective patients


Measures of success: How value-based pricing may change the pharmaceutical industry
  • Hogan Lovells
  • USA
  • June 1 2017

Adoption of value-based pricing, where drug prices are linked to real-world outcomes rather than on a per-pill or per-treatment basis, will have a


New FDA Commissioner Hits the Ground Running
  • Foley & Lardner LLP
  • USA
  • May 30 2017

Fresh off his noticeably smooth confirmation, the new Commissioner of Food and Drugs, Dr. Scott Gottlieb, appeared before Congress last Thursday and


Congressional Panels Tackle FDA Reauthorization Act and Other Health Policy Issues
  • Reed Smith LLP
  • USA
  • May 12 2017

On May 11, 2017, the Senate on Health, Education, Labor, and Pensions (HELP) Committee approved S 934, a bill extend Food and Drug Administration


The Critical Role of Telemedicine in the Addiction Crisis
  • Cozen O'Connor
  • USA
  • February 17 2017

Telemedicine is now mainstream. Surprisingly, however, one area in which telemedicine has not been used to its fullest capability is drug addiction


Congress Wants to Reform Agency Rulemaking: Refinements or Tectonic Shifts?
  • Epstein Becker Green
  • USA
  • January 25 2017

Congress is currently considering two bills that would dramatically alter the ways in which all federal agencies develop and publish rules. If


FDA Addresses Off-Label Promotion in Last Week of Obama Administration
  • Baker McKenzie
  • USA
  • January 24 2017

In the last week of the Obama administration, the Food and Drug Administration (FDA or Agency) released a document titled "Memorandum: Public Health